Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: jttmab who wrote (861)	1/11/1999 9:10:00 PM
From: Dan Spillane	Read Replies (1) \| Respond to of 2539

AHA! So Monsanto/Searle CAN say something about Celebrex being better...this isn't what the news is reporting! How much different is "less likely to have problems" from "safer"; they can say the first but not the second, apparently. What a bureaucratic mess! (from your story) "..though Searle can say that patients taking it are less likely to have those problems..." It just kills me to see the degree of mis-reporting applied to Celebrex and Monsanto in general. There are other stories involving mis-reporting, especially involving ABC News. (My earlier comment) By the way, there is one question still open in my mind that no one has answered. Is it true (as the news is reporting) that Monsanto got NO labeling changes, OR is there a label that will say the drug is safer, but still contain elements of the NSAID warning? What's the truth, hmmmmmm?